SOP for protocol amendments cultural considerations NZ – Clinical Research Made Simple https://www.clinicalstudies.in Trusted Resource for Clinical Trials, Protocols & Progress Fri, 05 Sep 2025 07:54:44 +0000 en-US hourly 1 https://wordpress.org/?v=6.9.1 SOP for Māori Consultation and Cultural Safety in Trial Design and Consent https://www.clinicalstudies.in/sop-for-maori-consultation-and-cultural-safety-in-trial-design-and-consent/ Fri, 05 Sep 2025 07:54:44 +0000 https://www.clinicalstudies.in/?p=7155 Read More “SOP for Māori Consultation and Cultural Safety in Trial Design and Consent” »

]]>
SOP for Māori Consultation and Cultural Safety in Trial Design and Consent

{
“@context”: “https://schema.org”,
“@type”: “Article”,
“mainEntityOfPage”: {
“@type”: “WebPage”,
“@id”: “https://www.clinicalstudies.in/maori-consultation-and-cultural-safety-in-trial-design-and-consent”
},
“@id”: “https://www.clinicalstudies.in/maori-consultation-and-cultural-safety-in-trial-design-and-consent”,
“headline”: “SOP for Māori Consultation and Cultural Safety in Trial Design and Consent”,
“name”: “SOP for Māori Consultation and Cultural Safety in Trial Design and Consent”,
“description”: “Comprehensive SOP describing responsibilities for Māori consultation, cultural safety, and informed consent design in clinical trials conducted in New Zealand, aligned with HDEC and GCP requirements.”,
“keywords”: “Māori consultation SOP, cultural safety SOP New Zealand, SOP for Māori engagement clinical trials, SOP for cultural considerations consent NZ, SOP for indigenous consultation NZ, SOP for community engagement Māori NZ, SOP for ethics submissions Māori consultation, SOP for HDEC cultural safety, SOP for Māori cultural protocols in trials, SOP for investigator responsibilities Māori consultation, SOP for sponsor cultural obligations NZ, SOP for trial design cultural considerations NZ, SOP for patient information Māori review, SOP for indigenous cultural advisors NZ, SOP for site-level cultural engagement NZ, SOP for CRO cultural responsibilities NZ, SOP for GCP compliance cultural safety NZ, SOP for ethics governance Māori consultation, SOP for consent cultural adaptation NZ, SOP for inspection readiness cultural aspects, SOP for trial subject protection Māori NZ, SOP for cultural approval documentation NZ, SOP for ethics cultural competency NZ, SOP for protocol amendments cultural considerations NZ, SOP for cultural training research staff NZ”,
“articleSection”: “Standard Operating Procedure”,
“datePublished”: “2025-08-28”,
“dateModified”: “2025-08-28”,
“author”: { “@type”: “Organization”, “name”: “Clinicalstudies.in” },
“publisher”: {
“@type”: “Organization”,
“name”: “Clinicalstudies.in”,
“logo”: { “@type”: “ImageObject”, “url”: “https://www.clinicalstudies.in/logo.png” }
}
}

Māori Consultation and Cultural Safety in Trial Design and Consent SOP

Department Clinical Research
SOP No. CS/NZ-HDEC/201/2025
Supersedes N.A.
Page No. 1 of 22
Issue Date 28/08/2025
Effective Date 05/09/2025
Review Date 05/09/2027

Purpose

The purpose of this SOP is to define procedures for engaging in Māori consultation and ensuring cultural safety in trial design and informed consent processes in New Zealand. It ensures respect for indigenous rights, cultural protocols, and compliance with Health and Disability Ethics Committees (HDEC) and GCP requirements.

Scope

This SOP applies to all clinical trials in New Zealand where Māori consultation is required. It covers early engagement with iwi (tribal) representatives, cultural safety reviews, translation and adaptation of participant information, and ethical oversight of informed consent. It applies to sponsors, investigators, CROs, and cultural advisors.

Responsibilities

  • Sponsor: Initiates Māori consultation during trial design and ensures cultural considerations are embedded.
  • Principal Investigator (PI): Engages with local Māori communities and ensures informed consent reflects cultural needs.
  • Regulatory Affairs (RA): Includes consultation evidence in submissions to HDEC.
  • Cultural Advisor: Provides expert review of consent forms and patient information materials for cultural appropriateness.
  • Quality Assurance (QA): Audits cultural consultation documentation and ensures compliance with HDEC guidance.

Accountability

The sponsor’s Clinical Operations Lead is accountable for initiating Māori consultation. The PI is accountable for ensuring cultural safety practices are observed at the site level.

Procedure

1. Early Engagement

  1. Identify Māori groups relevant to the trial’s geographic and therapeutic scope.
  2. Engage iwi representatives at trial planning stage.
  3. Document outcomes of engagement in Consultation Log (Annexure-1).

2. Trial Design Considerations

  1. Ensure cultural safety is reflected in recruitment strategies.
  2. Adapt participant information sheets (PIS) and consent forms for cultural relevance.

3. Informed Consent Process

  1. Ensure consent discussions are culturally appropriate, allowing whānau involvement.
  2. Offer translated or culturally adapted versions of ICF/PIS.

4. Documentation and Ethics Submission

  1. Include evidence of Māori consultation in ethics submissions to HDEC.
  2. Maintain acknowledgment from iwi representatives where applicable.

5. Monitoring and Audits

  1. QA team verifies that cultural safety processes are implemented and documented.
  2. CAPA actions must be initiated if gaps are identified.

Abbreviations

  • HDEC: Health and Disability Ethics Committees
  • PIS: Patient Information Sheet
  • ICF: Informed Consent Form
  • PI: Principal Investigator
  • RA: Regulatory Affairs
  • QA: Quality Assurance
  • CRO: Contract Research Organization
  • CAPA: Corrective and Preventive Action
  • Iwi: Tribal group in New Zealand
  • Whānau: Extended family network

Documents

  1. Consultation Log (Annexure-1)
  2. Cultural Review Log (Annexure-2)
  3. Informed Consent Adaptation Log (Annexure-3)

References

Version: 1.0

Approval

Prepared By Checked By Approved By
Name: Rajesh Kumar
Date: 20/08/2025
Signature: __________
Name: Sunita Reddy
Date: 22/08/2025
Signature: __________
Name: Dr. Meera Iyer
Date: 28/08/2025
Signature: __________

Annexures

Annexure-1: Consultation Log

Date Iwi Group Discussion Outcome Representative
05/08/2025 Ngāti Whātua Supportive of trial subject engagement Hemi Raukawa

Annexure-2: Cultural Review Log

Date Document Reviewer Comments
10/08/2025 PIS v1.0 Maria Te Rangi Recommended whānau inclusion statement

Annexure-3: Informed Consent Adaptation Log

Date ICF Version Adaptation Approved By
12/08/2025 v1.1 Added cultural guidance paragraph PI

Revision History

Revision Date Revision No. Revision Details Reason for Revision Approved By
28/08/2025 1.0 Initial SOP for Māori consultation and cultural safety in trial design and consent. New SOP created for New Zealand cultural and ethical compliance. Head of Clinical Research

For more SOPs visit: Pharma SOP.

]]>